Elisabetta Bandiera
University of Brescia
34 Papers
242 Citations
Elisabetta Bandiera is an academic researcher from University of Brescia. The author has contributed to research in topics: Ovarian cancer & Ovarian carcinoma. The author has an hindex of 23, co-authored 34 publications.
Chat about Author
Papers
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition
Siming Zhao,Stefania Bellone,Salvatore Lopez,Durga Thakral,Carlton L. Schwab,Diana P. English,Jonathan Black,Emiliano Cocco,Jungmin Choi,Luca Zammataro,Federica Predolini,Elena Bonazzoli,Mark Bi,Natalia Buza,Pei Hui,Serena Wong,Maysa M. Abu-Khalaf,Antonella Ravaggi,Eliana Bignotti,Elisabetta Bandiera,Chiara Romani,Paola Todeschini,Renata A. Tassi,Laura Zanotti,Franco Odicino,Sergio Pecorelli,Carla Donzelli,Laura Ardighieri,Fabio Facchetti,Marcella Falchetti,Dan-Arin Silasi,Elena Ratner,Masoud Azodi,Peter E. Schwartz,Shrikant Mane,Roberto Angioli,Corrado Terranova,Charles M. Quick,Babak Edraki,Kaya Bilguvar,Moses Lee,Murim Choi,Amy L. Stiegler,Titus J. Boggon,Joseph Schlessinger,Richard P. Lifton,Alessandro D. Santin +46 more
TL;DR: The genomes of uterine and ovarian CSs demonstrated that these different cell types derive from a common precursor cell that has many mutations typical of epithelial cancers, and expression of specific histone gene mutations in uterine carcinoma cells changed gene expression toward a mesenchymal state.
207
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management.
Elisabetta Bandiera,Chiara Romani,Claudia Specchia,Laura Zanotti,Claudio Galli,Giuseppina Ruggeri,Germana Tognon,Eliana Bignotti,Renata A. Tassi,Franco Odicino,Luigi Caimi,Enrico Sartori,Alessandro D. Santin,Sergio Pecorelli,Antonella Ravaggi +14 more
TL;DR: The high specificity of HE4 in discriminating endometriosis and ovarian benign cysts from EOC and the high sensitivity of CA125 in detecting EOC are underlined.
122
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients
Eliana Bignotti,Paola Todeschini,Stefano Calza,Marcella Falchetti,Maria Ravanini,Renata A. Tassi,Antonella Ravaggi,Elisabetta Bandiera,Chiara Romani,Laura Zanotti,Germana Tognon,Franco Odicino,Fabio Facchetti,Sergio Pecorelli,Alessandro D. Santin +14 more
TL;DR: The results indicate, for the first time, that Trop-2 protein overexpression correlates with an aggressive malignant phenotype and may constitute a novel prognostic factor for EOC.
114
HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study
C Romagnolo,Antonette E. Leon,Aline S.C. Fabricio,Martina Taborelli,Jerry Polesel,Lino Del Pup,Agostino Steffan,Silvia Cervo,Antonella Ravaggi,Laura Zanotti,Elisabetta Bandiera,Franco Odicino,Novella Scattolo,Elisa Squarcina,Christine Papadakis,Tiziano Maggino,Massimo Gion +16 more
TL;DR: HE4 seeming to be more efficient than CA125 in ruling in EOC patients in the disease group, also in early stages tumors, both in pre and postmenopause is suggested.
113
HE4 and epithelial ovarian cancer: Comparison and clinical evaluation of two immunoassays and a combination algorithm☆
Giuseppina Ruggeri,Elisabetta Bandiera,Laura Zanotti,Silvana Belloli,Antonella Ravaggi,Chiara Romani,Eliana Bignotti,Renata A. Tassi,Germana Tognon,Claudio Galli,Luigi Caimi,Sergio Pecorelli +11 more
TL;DR: HE4 was more specific and accurate than CA125, supporting its use in addition to clinical and imaging criteria for the discrimination of benign from malignant ovarian lesions.
107